Στρατηγική διοίκηση ESG και βιωσιμότητα στον φαρμακευτικό κλάδο
ESG strategy and sustainability in pharmaceutical industry
View/ Open
Keywords
ESG ; Sustainability ; Pharmaceutical industry ; Pharma 4.0 ; Μαύρος κύκνος ; Βιωσιμότητα ; Διακυβέρνηση ; Περιβαλλοντικά κριτήρια ; Πτυχές ESGAbstract
Sustainable development and ESG (Environmental, Social, Governance) principles have become essential for shaping strategies at both governmental and corporate levels. This paper examines the integration of these principles into the pharmaceutical industry, focusing on reducing the environmental footprint, enhancing social responsibility, and implementing transparent governance processes. Through the analysis of specific pharmaceutical companies, such as Pfizer and GSK, the study identifies the opportunities and challenges associated with adopting sustainable practices.
This research shows that the incorporation of ESG strategies can improve both the financial performance and the reputation of pharmaceutical companies, ensuring long-term success. However, significant challenges arise, including increased costs and the complexity of implementation. Overall, the paper suggests collaboration with governments and non-profit organizations to better manage risks and maximize the benefits of sustainable development.